Home » Advanced Oncotherapy (AVO) » Successful £20 million fundraising to complete installation of first LIGHT system at Harley St, London.

Successful £20 million fundraising to complete installation of first LIGHT system at Harley St, London.

Successful £20 million fundraising cheap jerseys to complete installation of first LIGHT system at Harley Wolthof St, London.

Advanced Oncotherapy announces that it has raised approximately wholesale MLB jerseys £20 million net of expenses, to continue the development of its LIGHT system, with the first unit expected to be installed in Harley Street, London, by the end of 2016 and first patient treatments expected in 2017.


· Placing of 262,500,000 new ordinary shares of 1 penny each at 8 pence per New Share to raise c. £20 million net of expenses

· Oversubscribed Placing with existing and new institutional investors by Westhouse Securities and Beaufort Securities, as joint brokers to the Company

· Admission to trading on AIM expected on 8 May 2015

· Funds to be used to complete the development of the Company’s first LIGHT system for cancer treatment

· The directors expect the Harley Street LIGHT system installation by the end of 2016 with patient treatments starting in 2017

· First commercial sales contract signed with Sinophi for China LIGHT installation for c. US$40 million

· Strong pipeline of installations (including SUNY AAA Upstate Medical University Hospital, New Save York, as well as Huai’an City China and letters of intent with Spire Healthcare and BMI Healthcare in the UK)

Sanjeev Pandya, CEO of Advanced Oncotherapy, said: “I am delighted that we have received such support from both our existing shareholders and a larger PDC institutional following as part of this fundraising. We are now well funded to ensure the successful delivery of our first LIGHT system which we expect to install in our prime UK location of Harley Street. We are on target to install our next-generation proton therapy system in the heart of London by the end of next year offering patients this life-changing treatment en in 2017. “The raising of these funds now, allows us as a management team to focus solely with on delivering this ground breaking technology to the UK to this timeline and we believe our success in doing so will generate significant value for shareholders.”

Share this post…

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.